Caina Technology Co

Caina Technology Co Debt Growth

The Year-over-Year Debt Growth of Caina Technology Co (301122.SZ) as of Oct 28, 2026 is 7,382.14 %. In the previous year, Year-over-Year Debt Growth was -5.80 % — a change of -127,377.43% (higher).

Debt Growth

7,382.14 %

YoY

-127,377.43%

Last updated:

Year-over-Year Debt Growth of Caina Technology Co is 2024 7,382.14 % . Year-over-Year Debt Growth of Caina Technology Co was 2023 -5.80 % . It decreases by -127,377.43% higher compared to the previous year.

The Caina Technology Co Debt Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt Growth
Date
Debt Growth
Jan 1, 2018
106.96 CNY
Jan 1, 2019
-27.40 CNY
Jan 1, 2020
-75.13 CNY
Jan 1, 2021
-99.43 CNY
Jan 1, 2022
323.56 CNY
Jan 1, 2023
-5.80 CNY
Jan 1, 2024
7,382.14 CNY
The Caina Technology Co Debt Growth history
YEARDebt GrowthYoY
7,382.14 %-127,377.43%
-5.80 %-101.79%
323.56 %-425.40%
-99.43 %+32.34%
-75.13 %+174.19%
-27.40 %-125.62%
106.96 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Year-over-Year Debt Growth of Caina Technology Co is 7,382.14 % in 2024.

On Eulerpool you can find the complete historical development of Year-over-Year Debt Growth Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Debt growth measures the percentage change in total debt. Rising debt growth should be compared with revenue and earnings growth to assess sustainability.

To evaluate Year-over-Year Debt Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Year-over-Year Debt Growth.

Year-over-Year Debt Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Year-over-Year Debt Growth's Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Caina Technology Co

All Key Metrics — Caina Technology Co